Somatic Structural Variation Signatures in Pediatric Brain Tumors

Overview

Journal Cell Rep

Publisher Cell Press

Specialties Biology
Cell Biology
Molecular Biology

Date 2023 Oct 18

PMID 37851574

Authors

Yang Yang

Lixing Yang

Affiliations

Soon will be listed here.

Abstract

Brain cancer is the leading cause of cancer-related death in children. Somatic structural variations (SVs), large-scale alterations in DNA, remain poorly understood in pediatric brain tumors. Here, we detect a total of 13,199 high-confidence somatic SVs in 744 whole-genome sequences of pediatric brain tumors from the Pediatric Brain Tumor Atlas. The somatic SV occurrences have tremendous diversity among the cohort and across different tumor types. We decompose mutational signatures of clustered complex SVs, non-clustered complex SVs, and simple SVs separately to infer their mutational mechanisms. Our finding of many tumor types carrying unique sets of SV signatures suggests that distinct molecular mechanisms shape genome instability in different tumor types. The patterns of somatic SV signatures in pediatric brain tumors are substantially different from those in adult cancers. The convergence of multiple SV signatures on several major cancer driver genes implies vital roles of somatic SVs in disease progression.

Citing Articles

Somatic DNA Variants in Epilepsy Surgery Brain Samples from Patients with Lesional Epilepsy.

Schwarz J, Becker L, Wahle M, Fassbender J, Thomale U, Tietze A Int J Mol Sci. 2025; 26(2.

PMID: 39859528 PMC: 11766355. DOI: 10.3390/ijms26020815.

Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors.

van Belzen I, van Tuil M, Badloe S, Janse A, Verwiel E, Santoso M Cell Genom. 2024; 4(11):100675.

PMID: 39406233 PMC: 11605687. DOI: 10.1016/j.xgen.2024.100675.

A review on trends in development and translation of omics signatures in cancer.

Ma W, Tang W, Kwok J, Tong A, Lo C, Chu A Comput Struct Biotechnol J. 2024; 23:954-971.

PMID: 38385061 PMC: 10879706. DOI: 10.1016/j.csbj.2024.01.024.

References

Degasperi A, Zou X, Amarante T, Martinez-Martinez A, Koh G, Dias J . Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. Science. 2022; 376(6591. PMC: 7613262. DOI: 10.1126/science.abl9283. View

Shoshani O, Brunner S, Yaeger R, Ly P, Nechemia-Arbely Y, Kim D . Chromothripsis drives the evolution of gene amplification in cancer. Nature. 2020; 591(7848):137-141. PMC: 7933129. DOI: 10.1038/s41586-020-03064-z. View

Jones D, Hutter B, Jager N, Korshunov A, Kool M, Warnatz H . Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet. 2013; 45(8):927-32. PMC: 3951336. DOI: 10.1038/ng.2682. View

Farmer H, McCabe N, Lord C, Tutt A, Johnson D, Richardson T . Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005; 434(7035):917-21. DOI: 10.1038/nature03445. View

Fong P, Boss D, Yap T, Tutt A, Wu P, Mergui-Roelvink M . Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009; 361(2):123-34. DOI: 10.1056/NEJMoa0900212. View

Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Kallberg M . Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 2015; 32(8):1220-2. DOI: 10.1093/bioinformatics/btv710. View

McVey M, Lee S . MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet. 2008; 24(11):529-38. PMC: 5303623. DOI: 10.1016/j.tig.2008.08.007. View

Alt F, Zhang Y, Meng F, Guo C, Schwer B . Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell. 2013; 152(3):417-29. PMC: 4382911. DOI: 10.1016/j.cell.2013.01.007. View

Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021; 23(8):1231-1251. PMC: 8328013. DOI: 10.1093/neuonc/noab106. View

10.

Jones D, Gronych J, Lichter P, Witt O, Pfister S . MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci. 2011; 69(11):1799-811. PMC: 3350769. DOI: 10.1007/s00018-011-0898-9. View

11.

Bakhshi A, Jensen J, Goldman P, Wright J, MCBRIDE O, Epstein A . Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985; 41(3):899-906. DOI: 10.1016/s0092-8674(85)80070-2. View

12.

Pfister S, Janzarik W, Remke M, Ernst A, Werft W, Becker N . BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008; 118(5):1739-49. PMC: 2289793. DOI: 10.1172/JCI33656. View

13.

Maciejowski J, Li Y, Bosco N, Campbell P, de Lange T . Chromothripsis and Kataegis Induced by Telomere Crisis. Cell. 2015; 163(7):1641-54. PMC: 4687025. DOI: 10.1016/j.cell.2015.11.054. View

14.

Rausch T, Zichner T, Schlattl A, Stutz A, Benes V, Korbel J . DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics. 2012; 28(18):i333-i339. PMC: 3436805. DOI: 10.1093/bioinformatics/bts378. View

15.

Li Y, Roberts N, Wala J, Shapira O, Schumacher S, Kumar K . Patterns of somatic structural variation in human cancer genomes. Nature. 2020; 578(7793):112-121. PMC: 7025897. DOI: 10.1038/s41586-019-1913-9. View

16.

Bao L, Zhong X, Yang Y, Yang L . Starfish infers signatures of complex genomic rearrangements across human cancers. Nat Cancer. 2022; 3(10):1247-1259. PMC: 11077613. DOI: 10.1038/s43018-022-00404-y. View

17.

Bunting S, Nussenzweig A . End-joining, translocations and cancer. Nat Rev Cancer. 2013; 13(7):443-54. PMC: 5724777. DOI: 10.1038/nrc3537. View

18.

Ng P, Henikoff S . SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13):3812-4. PMC: 168916. DOI: 10.1093/nar/gkg509. View

19.

Zhang F, Khajavi M, Connolly A, Towne C, Batish S, Lupski J . The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet. 2009; 41(7):849-53. PMC: 4461229. DOI: 10.1038/ng.399. View

20.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View